SUTENT vs TABRECTA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 19, 2026·How we rate

Possible drug interaction. SUTENT and TABRECTA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	SUTENT	TABRECTA
Rating	New	70/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	SUNITINIB MALATE	CAPMATINIB HYDROCHLORIDE
Manufacturer	Cppi Cv	Novartis
Dosage forms	Capsule	Tablet
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	Boxed warning	None
Treats	Renal Cell Carcinoma, Pancreatic Neoplasms, Neuroendocrine Tumors	Non-Small-Cell Lung Carcinoma

sutent tabrecta

Rating

New

70/100

Pharmacy pays

—

Type

Active ingredient

SUNITINIB MALATE

CAPMATINIB HYDROCHLORIDE

Manufacturer

Cppi Cv

Novartis

Dosage forms

Capsule

Tablet

Drug class

Kinase Inhibitor

Boxed warning

None

Treats

Renal Cell Carcinoma, Pancreatic Neoplasms, Neuroendocrine Tumors

Non-Small-Cell Lung Carcinoma

Frequently asked questions

What is the difference between Sutent and Tabrecta?

Sutent contains Sunitinib Malate, while Tabrecta contains Capmatinib Hydrochloride — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.